Recurrent Prostate Cancer Clinical Trials
2 recruiting trials for Recurrent Prostate Cancer. Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGPhase 2NCT06096870
Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy
Background: Prostate cancer may return after treatment in 30,000 to 50,000 people each year. There is no clear best way to treat these people. Better treatments are needed....
Sponsor: National Cancer Institute (NCI)Enrolling: 651 location
RECRUITINGPhase 1 / Phase 2NCT03067051
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
The rationale for the study is to obtain safety and efficacy data as well as to establish dose parameters for the SpectraCure P18 System with IDOSE®, with verteporfin for...
Sponsor: SpectraCure ABEnrolling: 664 locations